A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma

Tumor-induced hypoglycemia (TIH) associated with hepatocellular carcinoma (HCC) results from tumor production of insulin-like growth factor 2 (IGF-2), resulting in recurrent hypoglycemia. Serum levels of insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), or pro-insulin-like...

Full description

Bibliographic Details
Main Authors: Prachi Rana, Brian Kim
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/4601484
_version_ 1798045360230236160
author Prachi Rana
Brian Kim
author_facet Prachi Rana
Brian Kim
author_sort Prachi Rana
collection DOAJ
description Tumor-induced hypoglycemia (TIH) associated with hepatocellular carcinoma (HCC) results from tumor production of insulin-like growth factor 2 (IGF-2), resulting in recurrent hypoglycemia. Serum levels of insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), or pro-insulin-like growth factor 2 (pro-IGF-2) are required for the diagnosis. However, due to the limited availability of testing in many laboratories, this condition is often overlooked. As this condition is often overlooked, prompt recognition and implementation of tumor directed therapies and/or systemic therapies can help mitigate the consequences of hypoglycemia. We present a 38-year-old man with advanced multifocal HCC who presented with abdominal pain and was found to have recurrent symptomatic hypoglycemia. Evaluation revealed elevated levels of IGF-2, suggesting a diagnosis of HCC with production of IGF-2.
first_indexed 2024-04-11T23:19:31Z
format Article
id doaj.art-10abfc0b658a417f8402bc34ba6dfba9
institution Directory Open Access Journal
issn 2090-6501
2090-651X
language English
last_indexed 2024-04-11T23:19:31Z
publishDate 2019-01-01
publisher Hindawi Limited
record_format Article
series Case Reports in Endocrinology
spelling doaj.art-10abfc0b658a417f8402bc34ba6dfba92022-12-22T03:57:30ZengHindawi LimitedCase Reports in Endocrinology2090-65012090-651X2019-01-01201910.1155/2019/46014844601484A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular CarcinomaPrachi Rana0Brian Kim1Department of Internal Medicine, Los Angeles County Hospital/University of Southern California, USADepartment of Gastroenterology and Liver Diseases, Los Angeles County Hospital/University of Southern California, USATumor-induced hypoglycemia (TIH) associated with hepatocellular carcinoma (HCC) results from tumor production of insulin-like growth factor 2 (IGF-2), resulting in recurrent hypoglycemia. Serum levels of insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), or pro-insulin-like growth factor 2 (pro-IGF-2) are required for the diagnosis. However, due to the limited availability of testing in many laboratories, this condition is often overlooked. As this condition is often overlooked, prompt recognition and implementation of tumor directed therapies and/or systemic therapies can help mitigate the consequences of hypoglycemia. We present a 38-year-old man with advanced multifocal HCC who presented with abdominal pain and was found to have recurrent symptomatic hypoglycemia. Evaluation revealed elevated levels of IGF-2, suggesting a diagnosis of HCC with production of IGF-2.http://dx.doi.org/10.1155/2019/4601484
spellingShingle Prachi Rana
Brian Kim
A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
Case Reports in Endocrinology
title A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
title_full A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
title_fullStr A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
title_full_unstemmed A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
title_short A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
title_sort unique case of igf 2 induced hypoglycemia associated with hepatocellular carcinoma
url http://dx.doi.org/10.1155/2019/4601484
work_keys_str_mv AT prachirana auniquecaseofigf2inducedhypoglycemiaassociatedwithhepatocellularcarcinoma
AT briankim auniquecaseofigf2inducedhypoglycemiaassociatedwithhepatocellularcarcinoma
AT prachirana uniquecaseofigf2inducedhypoglycemiaassociatedwithhepatocellularcarcinoma
AT briankim uniquecaseofigf2inducedhypoglycemiaassociatedwithhepatocellularcarcinoma